glp-1 comparison chart weight loss Is Toujeo a GLP-1? The critical difference explained Both Ro and Hims offer

These are tiny sample sizes by medical research standards

Patients need to choose treatments backed by solid clinical proof

The win: the Wegovy pill (oral semaglutide 25 mg), launched January 5, 2026, generated $354 million in its first full quarter, doubling analyst estimates

Most successful maintainers weigh at least weekly Immediate response to regain

Improves Glycemic Control: In persons with type 2 diabetes, retatrutide lowers HbA1c and fasting glucose levels, with efficacy sometimes exceeding established glucose-lowering medications 1,2

A major meta-analysis finds that patients who discontinue anti-obesity medications quickly regain weight, yet, crucially, they still retain some of their original weight loss a year later, spotlighting the challenges and promise of long-term obesity treatment